Breast cancer specialists throw their weight behind long-running fight

New Zealand’s Breast Special Interest Group (BSIG) has written to the Health Select Committee saying many breast cancer patients who can’t afford to pay for certain medicines themselves have shorter lives and poorer quality of life.

The committee is considering two petitions from Metavivors calling for the funding of two medicines for advanced breast cancer – Ibrance and Kadcyla.

The submission is signed by BSIG group chair Dr Reuben Broom and secretary Dr Sarah Barton, and calls for more money for  PHARMAC to give those with breast cancer more treatment options at affordable prices.

Date published